雷公藤联合小剂量强的松治疗老年类风湿关节炎的疗效观察被引量：2

Curative effect observation of tripterygium wilfordii combined with small dose of prednisone in the treatment of senile rheumatoid arthritis

暂未订购

导出

摘要目的观察雷公藤联合小剂量强的松治疗老年类风湿关节炎(RA)的临床疗效和安全性。方法 52例老年RA患者随机分为治疗组和对照组;治疗组(26例)口服雷公藤和小剂量强的松治疗,对照组(26例)口服雷公藤治疗,比较治疗前后两组患者临床症状和实验室指标的变化。结果治疗3个月后治疗组患者在晨僵时间、关节压痛数、关节肿胀数、患者VAS评分、红细胞沉降率(ESR)、C反应蛋白(CRP)、类风湿因子(RF)、DAS28指标上改善优于对照组(P<0.05),且两组治疗3个月后各项指标与治疗前比较,差异有统计学意义(P<0.05);治疗组患者ACR20、ACR50、ACR70缓解率优于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论雷公藤联合小剂量强的松治疗老年类风湿关节炎能快速改善临床症状和实验室指标,不良反应少。 Objective To observe the clinical effect and safety of tripterygium wilfordii combined with small dose of prednisone in the treatment of senile rheumatoid arthritis （RA）. Methods A total of 52 cases of senile RA were randomly divided into treatment group and control group. The treatment group （n=26） received treatment of tripterygium wilfordii and small dose of prednisone, and the control group （n=26） received treatment of tripterygium wilfordii. Clinical symptoms and lab index changes of two groups before and after treatment were compared. Results The stiffness time, joint tenderness count, joint swelling count, patient VAS score, erythrocyte sedimentation rate （ESR）, C-reactive protein （CRP）, rheumatoid factor （RF） and DAS28 index of the treatment group patients were better than that of the control group after 3 months （P〈0.05）. These indexes of the two groups had significant differences, compared with those before the treatment （P〈0.05）. The ACR20, ACR50 and ACRT0 remission rate of the treatment group were better than that of the control group （P〈0.05）. There was no statistically significance in the difference of adverse reaction rate between the two groups （P〉0.05）. Conclusion The treatment of tripterygium wilfordii combine with small dose of prednisone in patients with senile rheumatoid arthritis can quickly improve the clinical symptoms and laboratory indexes, and has less adverse reactions.

作者喻少波吴敏

机构地区江苏省常州市第一人民医院风湿科

出处《中国实用医药》 2014年第29期42-43,共2页 China Practical Medicine

关键词老年类风湿关节炎雷公藤小剂量强的松 Senile rheumatoid arthritis Tripterygium wilfordii Small dose of prednisone

分类号 R593.22 [医药卫生—内科学]

引文网络
相关文献

参考文献5

1栗占国.老年类风湿关节炎的治疗[J].老年医学与保健,2003,9(3):137-140. 被引量：19
2Leeb BF, Andel I, Leder S, et al. The patients prespective and rheumatoid arthritis disease activity indexes. Rheumatology, 2005, 44(3):360-365.
3American College of Rheumatology Committee Reevaluate Improvement Criteria. A propose revision to the ACR20:hybrid measure of american college of rheumatology response. Arthritis Rheum, 2007, 57(2): 193-202.
4栗占国,王慧.老年类风湿关节炎的诊治进展[J].实用老年医学,2008,22(1):7-11. 被引量：32
5Gomez CG, Nolla TM, Valverde j, et al. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. Eur J Clin Invest, 2008, 38(9): 686-692.

二级参考文献31

1O'Dell JR. Left R, Paulsen G, et al. Trealment of rheumatoid arthritis with methotrexate and hydmxyehloroqulne, methotrexate and sulfasalazine, or a combination of the three medications: results of a two - year. randomized, double - blind, placebo - controlled trial. Arthritis Rheum, 2002, 46(5): 1164 - 1170.
2Kremer JM. Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arlhritis despite stable doses of merhotrexate. A randomized, double- blind,placebo - controlled trial. Ann Intern Med, 2002, 137(9): 726 -733.
3Totokawa S. Furuya T, Nakajima A, et al. Effects of low dose methotrexate Iherapy in rheumaloid arthritis: a comparison of three different dosage regimens. Ryumachi, 1997, 37 (5): 681 -687.
4Glennas A, Kvien TK, Andrup O, et al. Auranofin is safe and superior to placebo in elderly - onset rheumatoid arthritis. Br J Rheum, 1997, 36:870 - 877.
5Favalli EG, Sinigaglia L, Varenna M, et al. Drug- induced lupus following treatment with infliximab in rheumatoid arthritis.Lupus,2002, 11 ( 11 ) :753 - 755.
6Brown SL, Greene MH, Gershon SK. et al. Tumor necrosis factor antagonist therapy and lymphnma development: twenty- six cases reported to the Food and Drug administration. Arthritis Rheum, 2002,46( 12): 3151 - 3158.
7Lockie LM, Gomez E, Smith DM.Low dose adrenocorticosteroids in the management of elderly patients and summary of efficacy in the long-term treatment of 97 patients .Semin Arthritis Rheum,1983,12(4):373 - 381.
8Conn DL,Lim SS. New role for an old friend: prednisone is a disease- modifying agent in early RA. Curr Opin Rheumatol, 2003,15(3): 2193 -2196.
9ACR Subcommittee on rheumatoid arthrilis guidelines, Guidelines for the management of rheumatoid arthritis. Arthritis Rheum, 2002, 46(2): 328 - 346.
10Emery P. Evidence supporting the benefit of early intervention in rheumatoid arthritis .J Rheumatol Suppl , 2002, 66:3 - 8.